Skip to main content
Clinical Trials/NCT03498911
NCT03498911CompletedNot Applicable

Comparison of Envelope Coronally Advanced Flap and Modified Tunnel Technique in Soft Tissue Dehiscence Coverage Around Implants: A Randomized Clinical Trial

University of Michigan2 sites in 1 country28 target enrollmentStarted: July 10, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
28
Locations
2
Primary Endpoint
mean mid-facial recession coverage (mRC)

Study Overview

Brief Summary

The purpose of this study is to assess the influence of two different flap designs (envelope Coronally Advanced Flap (eCAF) and Modified Tunnel Technique (MTT)) with the addition of a connective tissue graft (CTG) in treating soft tissue dehiscences at implant sites

Detailed Description

The primary aim is to compare the test and control groups in terms of:

  1. mean mid-facial recession coverage (mRC) measured as a percentage
  2. the keratinized tissue (KT) gain measured in mm
  3. the keratinized tissue thickness (KTT) gain measured in mm.

The secondary aims are to compare the two groups in terms of:

  1. Esthetic score, using numeric values from 0 to 10
  2. patient-reported esthetics, using numeric values from 1 to 5
  3. patient-reported post-operative pain, based on Visual Analog Scale (VAS) scale, measured as numbers from 0 to 10.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 years
  • Periodontally and systemically healthy
  • Full-mouth plaque score and full-mouth bleeding score ≤ 20% (measured at four sites per tooth)
  • Correct implant 3-dimensional position or buccal position ≤ 1 mm
  • Buccal soft tissue dehiscence ≤ 4 mm
  • Only osseointegrated implants
  • The patient must be able to perform good oral hygiene

Exclusion Criteria

  • Contraindications for periodontal surgery
  • Patients pregnant or attempting to get pregnant
  • Malpositioned implant
  • Soft tissue dehiscence (STD) > 4 mm
  • Multiple adjacent implants with STD
  • Existing of peri-implantitis
  • Severe bone loss (≥4mm)
  • Moderate-severe interproximal bone loss (implant fixture level to the alveolar bone > 3 mm)
  • Moderate-severe papilla height loss (Nordland and Tarnow implant papillae index >1)
  • Previous mucogingival surgery around the implant within the past six months or implant placement at the surgical site less than six months prior
  • Smoking more than 10 cigarettes a day

Outcomes

Primary Outcomes

mean mid-facial recession coverage (mRC)

Time Frame: up to 1 year

mRC measured as a percentage

Secondary Outcomes

  • Esthetic score(6 months and 1 year)
  • Patient-reported esthetics(6 months and 1 year)
  • Keratinized tissue thickness (KTT)(6 months and 1 year)
  • Patient-reported post-operative pain(2 weeks)
  • Keratinized tissue (KT) gain(6 months and 1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hom-Lay Wang, DDS, MSD, Ph D

Collegiate Professor of Periodontics and Professor of Dentistry

University of Michigan

Study Sites (2)

Loading locations...

Similar Trials

Comparison of Envelope Coronally Advanced... | Clinical Trial